NCT07764185RecruitingPhase 2
Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease
Recharge Behavioral Therapy for Caregivers of Individuals With Alzheimer's Disease
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
This project will evaluate the effectiveness of the Recharge Behavioral Therapy (RBT) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 9 Aug 2026
- Start date
- 14 Aug 2026
- Primary completion date
- 31 May 2027
- Lead sponsor
- Photozig, Inc.
- Diseases
- Alzheimer disease
- NCT number
- NCT07764185
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 150
- From 14 Aug 2026 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe psychological or physical illness.
Other
- Inability to read and follow instructions.
- Unwillingness to participate in all aspects of the study.
Who the study is looking for
- Care for an individual with Alzheimer s Disease or other dementia.
- Have a Smartphone or tablet with Internet access.
- Minimum age of 18 years old.
- Spend at least 8 hours/week caring for a person with dementia.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Photozig, Inc. Coordinator of this site? Confirm its status | Campbell | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.